Orphazyme AS (CHIX:ORPHAC) EV-to-Revenue : -0.41 (As of Jun. 23, 2024)

Orphazyme AS EV-to-Revenue Chart

Orphazyme AS Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
EV-to-Revenue	Get a 7-Day Free Trial									-	-	-	14.85	-

Competitive Comparison of Orphazyme AS's EV-to-Revenue

For the Biotechnology subindustry, Orphazyme AS's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orphazyme AS's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's EV-to-Revenue falls into.

Orphazyme AS EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Orphazyme AS's EV-to-Revenue for today is calculated as:

Orphazyme AS's current Enterprise Value is kr-14.76 Mil.
Orphazyme AS's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was kr36.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orphazyme AS  (CHIX:ORPHAc) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Orphazyme AS's PS Ratiofor today is calculated as:

Orphazyme AS's share price for today is kr8425.00.
Orphazyme AS's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,034.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orphazyme AS EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS (CHIX:ORPHAC) Business Description